We are live on
!
Find out more
LCP
LGT Capital Partners Portfolio holdings
AUM
$1.88B
1-Year Est. Return
20.37%
This Fund
S&P 500
This Quarter
Est. Return
+3.87%
1 Year Est. Return
+20.37%
3 Year Est. Return
+55.13%
5 Year Est. Return
+61.29%
10 Year Est. Return
+259.47%
AUM
$993M
AUM Growth
-$2.93M
(-0.29%)
Cap. Flow
-$38.4M
Cap. Flow
% of AUM
-3.87%
Top 10 Holdings %
Top 10 Hldgs %
32.94%
Holding
68
New
3
Increased
32
Reduced
28
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Akamai
AKAM
|
+$14.5M |
| 2 |
T-Mobile US
TMUS
|
+$13.1M |
| 3 |
TUP
Tupperware Brands Corporation
TUP
|
+$12.9M |
| 4 |
Urban Outfitters
URBN
|
+$11.1M |
| 5 |
Keurig Dr Pepper
KDP
|
+$7.42M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$34.6M |
| 2 |
Intuitive Surgical
ISRG
|
+$23.3M |
| 3 |
Pediatrix Medical
MD
|
+$13M |
| 4 |
Apple
AAPL
|
+$12.6M |
| 5 |
Oracle
ORCL
|
+$9.86M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 23.85% |
| 2 | Consumer Staples | 15.01% |
| 3 | Technology | 13.86% |
| 4 | Healthcare | 12.2% |
| 5 | Communication Services | 7.16% |
Similar funds
SGF
TF
VC
PCM
JPG
OPCM
PCP
EPW
LGT Capital Partners's Q3 2017 Portfolio in Review
As of Q3 2017, LGT Capital Partners held 68 positions worth $993M, down 0.29% from $996M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
LGT Capital Partners withdrew a net $38.4M in Q3 2017, closing 5 positions and reducing 28 holdings. Its most notable exit was Pediatrix Medical, an estimated $13M position sold in full.
By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 23% a quarter earlier, followed by Consumer Staples and Technology.
Against the trend, LGT Capital Partners opened a new position in T-Mobile US worth $12.9M.
- LGT Capital Partners's largest Q3 2017 buy was T-Mobile US: 209,330 shares worth $12.9M.
- LGT Capital Partners added most to Akamai in Q3 2017, an estimated $14.5M increase.
- LGT Capital Partners's biggest Q3 2017 reduction was Biogen, cutting an estimated $34.6M.
- LGT Capital Partners fully exited Pediatrix Medical in Q3 2017, selling an estimated $13M.
- LGT Capital Partners's ten largest holdings make up 33% of its $993M portfolio in Q3 2017.
- LGT Capital Partners opened 3 new positions and closed 5 in Q3 2017.
- LGT Capital Partners's portfolio value fell 0.29% quarter-over-quarter to $993M.
Based on LGT Capital Partners's 13F filing for Q3 2017, filed 11 Oct 2017.